» Articles » PMID: 9820397

Health-related Quality of Life in Swedish Patients with Ulcerative Colitis

Overview
Specialty Gastroenterology
Date 1998 Nov 20
PMID 9820397
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this study was to characterize the health-related quality of life (HRQOL) in a Swedish population of patients with ulcerative colitis.

Methods: A total of 211 patients with ulcerative colitis were studied. Demographic and disease-related factors were noted. HRQOL was measured by one disease specific questionnaire, the Rating Form of IBD Patient Concerns (RFIPC) and one generic, The Sickness Impact Profile (SIP). Additional questions regarding information needs, medication, and well-being were asked. Disease activity was measured by symptom cards, laboratory samples, endoscopy, and two indices of disease activity. The influence of additional concomitant disease was also evaluated.

Results: Functional impairment as measured by the SIP was primarily in psychological and social areas and to a lesser extent in the physical areas. The highest scores for individual items of the RFIPC were those related to potential complications, e.g., needing an ostomy appliance, needing surgery, developing cancer, losing bowel control, and uncertainty about the disease and effects of medication. Patients with active disease scored higher on both SIP and RFIPC when compared to patients in remission. Presence of coexisting disease weighted heavily on HRQOL.

Conclusion: Ulcerative colitis has a negative influence on the subjective functional status and seems to cause many worries and concerns. Patients in relapse had greater concerns, more impairment of functional status, and a reduced subjective sense of well-being than patients in clinical remission. Nevertheless, the patients in this Swedish study scored a much better HRQOL than has previously been reported using these questionnaires in patients with ulcerative colitis from the US, France, and Austria.

Citing Articles

Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life.

Ozer M, Bengi G, Colak R, Cengiz O, Akpinar H Medicine (Baltimore). 2020; 99(19):e20067.

PMID: 32384473 PMC: 7220554. DOI: 10.1097/MD.0000000000020067.


Health-related quality of life of patients with inflammatory bowel disease in Singapore.

Min Ho P, Hu W, Lee Y, Gao C, Tan Y, Cheen H Intest Res. 2018; 17(1):107-118.

PMID: 30419638 PMC: 6361019. DOI: 10.5217/ir.2018.00099.


Disease impact on the quality of life of children with inflammatory bowel disease.

Chouliaras G, Margoni D, Dimakou K, Fessatou S, Panayiotou I, Roma-Giannikou E World J Gastroenterol. 2017; 23(6):1067-1075.

PMID: 28246481 PMC: 5311096. DOI: 10.3748/wjg.v23.i6.1067.


Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicator.

Pittet V, Vaucher C, Froehlich F, Burnand B, Michetti P, Maillard M PLoS One. 2017; 12(2):e0171864.

PMID: 28187201 PMC: 5302448. DOI: 10.1371/journal.pone.0171864.


The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.

Conway G, Velonias G, Andrews E, Garber J, Yajnik V, Ananthakrishnan A Aliment Pharmacol Ther. 2017; 45(6):814-823.

PMID: 28105709 PMC: 5315585. DOI: 10.1111/apt.13940.